188 related articles for article (PubMed ID: 32224063)
1. Predictors of treatment outcome of Wilms Tumour in low-income country; single centre experience from Pakistan.
Ghafoor T; Bashir F; Ahmed S; Khalil S; Farah T
J Pediatr Urol; 2020 Jun; 16(3):375.e1-375.e7. PubMed ID: 32224063
[TBL] [Abstract][Full Text] [Related]
2. Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG).
van den Heuvel-Eibrink MM; van Tinteren H; Bergeron C; Coulomb-L'Hermine A; de Camargo B; Leuschner I; Sandstedt B; Acha T; Godzinski J; Oldenburger F; Gooskens SL; de Kraker J; Vujanic GM; Pritchard-Jones K; Graf N
Eur J Cancer; 2015 Mar; 51(4):498-506. PubMed ID: 25592561
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of children with Wilms tumor treated on a SIOP WT 2001 protocol in a tertiary care hospital in south India.
John R; Kurian JJ; Sen S; Gupta MK; Jehangir S; Mathew LG; Mathai J
J Pediatr Urol; 2018 Dec; 14(6):547.e1-547.e7. PubMed ID: 30017606
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of age in 5631 patients with Wilms tumour prospectively registered in International Society of Paediatric Oncology (SIOP) 93-01 and 2001.
Hol JA; Lopez-Yurda MI; Van Tinteren H; Van Grotel M; Godzinski J; Vujanic G; Oldenburger F; De Camargo B; Ramírez-Villar GL; Bergeron C; Pritchard-Jones K; Graf N; Van den Heuvel-Eibrink MM
PLoS One; 2019; 14(8):e0221373. PubMed ID: 31425556
[TBL] [Abstract][Full Text] [Related]
5. Outcome of patients with stage IV high-risk Wilms tumour treated according to the SIOP2001 protocol: A report of the SIOP Renal Tumour Study Group.
Pasqualini C; Furtwängler R; van Tinteren H; Teixeira RAP; Acha T; Howell L; Vujanic G; Godzinski J; Melchior P; Smets AM; Coulomb-L'Hermine A; Brisse H; Pritchard-Jones K; Bergeron C; de Camargo B; van den Heuvel-Eibrink MM; Graf N; Verschuur AC
Eur J Cancer; 2020 Mar; 128():38-46. PubMed ID: 32109849
[TBL] [Abstract][Full Text] [Related]
6. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and Clinical Outcomes of Children With Wilms' Tumour: A 15-year Experience in a Single Centre in Nigeria.
Nasir AA; Abdur-Raheem NT; Abdur-Rahman LO; Ibiyeye TT; Sayomi TO; Adedoyin OT; Adeniran JO
J Pediatr Surg; 2024 May; 59(5):1009-1014. PubMed ID: 38184433
[TBL] [Abstract][Full Text] [Related]
8. Management and outcome of pediatric metastatic Wilms' tumor at the National Cancer Institute, Egypt.
Elayadi M; Magdy S; Khalil E; Zekri W
J Egypt Natl Canc Inst; 2020 Apr; 32(1):19. PubMed ID: 32372204
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and outcomes of preoperatively treated patients with anaplastic Wilms tumors registered in the UK SIOP-WT-2001 and IMPORT study cohorts (2002-2020).
Vujanić GM; Mifsud W; Chowdhury T; Al-Saadi R; Pritchard-Jones K;
Cancer; 2022 Apr; 128(8):1666-1675. PubMed ID: 35119702
[TBL] [Abstract][Full Text] [Related]
10. Stromal and epithelial predominant Wilms tumours have an excellent outcome: the SIOP 93 01 experience.
Verschuur AC; Vujanic GM; Van Tinteren H; Jones KP; de Kraker J; Sandstedt B
Pediatr Blood Cancer; 2010 Aug; 55(2):233-8. PubMed ID: 20582946
[TBL] [Abstract][Full Text] [Related]
11. A higher tumor volume and undernutrition at diagnosis adversely affect the survival of children with Wilms tumor: A study of 200 patients.
Rahiman EA; Trehan A; Jain R; Menon P; Kakkar N; Srinivasan R; Sodhi KS; Saxena AK; Kapoor R; Bansal D
Pediatr Blood Cancer; 2022 Nov; 69(11):e29880. PubMed ID: 35841309
[TBL] [Abstract][Full Text] [Related]
12. Bilateral Wilms tumors: Treatment results from a single center.
Aydın B; Akyüz C; Yalçın B; Ekinci S; Oğuz B; Akçören Z; Yıldız F; Varan A; Kurucu N; Büyükpamukçu M; Kutluk T
Turk J Pediatr; 2019; 61(1):44-51. PubMed ID: 31559721
[TBL] [Abstract][Full Text] [Related]
13. Hepatic metastasis at diagnosis in patients with Wilms tumor is not an independent adverse prognostic factor for stage IV Wilms tumor: a report from the Children's Oncology Group/National Wilms Tumor Study Group.
Ehrlich PF; Ferrer FA; Ritchey ML; Anderson JR; Green DM; Grundy PE; Dome JS; Kalapurakal JA; Perlman EJ; Shamberger RC
Ann Surg; 2009 Oct; 250(4):642-8. PubMed ID: 19730241
[TBL] [Abstract][Full Text] [Related]
14. Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group.
Mitchell C; Pritchard-Jones K; Shannon R; Hutton C; Stevens S; Machin D; Imeson J; Kelsey A; Vujanic GM; Gornall P; Walker J; Taylor R; Sartori P; Hale J; Levitt G; Messahel B; Middleton H; Grundy R; Pritchard J;
Eur J Cancer; 2006 Oct; 42(15):2554-62. PubMed ID: 16904312
[TBL] [Abstract][Full Text] [Related]
15. Minichromosome maintenance 2 (MCM2) is a new prognostic proliferative marker in Wilms tumour.
Taran K; Sitkiewicz A; Andrzejewska E; Kobos J
Pol J Pathol; 2011; 62(2):84-8. PubMed ID: 21866463
[TBL] [Abstract][Full Text] [Related]
16. Relapsed Wilms' tumor in pediatric patients: challenges in low- to middle-income countries-a single-center experience.
Zekri W; Yacoub DM; Ibrahim A; Madney Y
J Egypt Natl Canc Inst; 2020 May; 32(1):21. PubMed ID: 32372372
[TBL] [Abstract][Full Text] [Related]
17. Wilms' tumor: the experience of the pediatric unit of Kasr El-Aini center of radiation oncology and nuclear medicine (NEMROCK).
Abd El-Aal HH; Habib EE; Mishrif MM
J Egypt Natl Canc Inst; 2005 Dec; 17(4):308-14. PubMed ID: 17102824
[TBL] [Abstract][Full Text] [Related]
18. Wilms' tumour: a comparison of surgical aspects in patients with or without pre-operative chemotherapy.
Safdar CA; Aslam M; Awan SH; Ahmed I; Badshah S
J Coll Physicians Surg Pak; 2006 Aug; 16(8):521-4. PubMed ID: 16899180
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of non-anaplastic stage III and 'inoperable' Wilms tumour treated in the UKW3 trial.
Irtan S; Messahel B; Moroz V; Taylor RE; Grundy R; Kelsey A; Vujanic G; Pritchard-Jones K;
Radiother Oncol; 2019 Feb; 131():1-7. PubMed ID: 30773174
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of pre-referral tumor resection in unilateral Wilms tumor: A single-institute experience from a lower middle-income country.
Khan MS; Maaz AUR; Qazi AQ; Aslam S; Riaz S; Malik AS; Shaheen N
Pediatr Blood Cancer; 2024 Feb; 71(2):e30760. PubMed ID: 37962283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
